Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

13.16
+0.73005.87%
Pre-market: 13.10-0.0600-0.46%05:32 EDT
Volume:7.07M
Turnover:93.15M
Market Cap:10.50B
PE:-11.77
High:13.53
Open:12.69
Low:12.57
Close:12.43
52wk High:30.05
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:0.98
T/O Rate:4.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:16.66
PE(LYR):-9.11

Loading ...

UK Vehicle Production Plummets in February Amid Export Weakness

Deep News
·
Mar 27

Analysts Are Bullish on Top Healthcare Stocks: Scholar Rock Holding (SRRK), Summit Therapeutics (SMMT)

TIPRANKS
·
Mar 20

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

Reuters
·
Mar 16

Is Summit Therapeutics (SMMT) Now Pricing In Too Much Hope After Strong Multi Year Gains

Simply Wall St.
·
Mar 04

H.C. Wainwright Sticks to Its Buy Rating for Summit Therapeutics (SMMT)

TIPRANKS
·
Mar 02

Summit Therapeutics to Present at TD Cowen, Jefferies, and Citizens Life Sciences Investor Conferences

Reuters
·
Feb 27

Wells Fargo Keeps Their Buy Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
Feb 25

Summit Therapeutics (SMMT) Receives a Buy from Evercore ISI

TIPRANKS
·
Feb 24

Assessing Summit Therapeutics (SMMT) Valuation After Recent Share Price Swings

Simply Wall St.
·
Feb 24

Summit Therapeutics Plc : H.c. Wainwright Cuts Target Price to $30 From $40

THOMSON REUTERS
·
Feb 24

Citi adds ‘upside 90-day catalyst watch’ on Summit Therapeutics

TIPRANKS
·
Feb 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Summit Therapeutics (SMMT)

TIPRANKS
·
Feb 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT) and Community Health (CYH)

TIPRANKS
·
Feb 24

Summit Therapeutics Q4 net loss widens on rise in expenses

Reuters
·
Feb 24

Summit reports FY 2025 GAAP operating expenses of USD 1.09B up 384%

Reuters
·
Feb 24

BRIEF-Summit Therapeutics Q4 Net Income USD -219.2 Million

Reuters
·
Feb 24

Summit Therapeutics Q4 Operating Expenses USD 225 Million

THOMSON REUTERS
·
Feb 24